SCHEMBL17826621

SCHEMBL17826621

CSP1(=O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)C(O)C2O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ THRB P10828 1/20 0.47
▸ MTOR P42345 1/20 0.47
▸ MDM2 Q00987 1/20 0.47
▸ NCOA1 Q15788 1/20 0.47
▸ NCOA3 Q9Y6Q9 1/20 0.47
▸ RAPGEF3 O95398 3/20 0.46
▸ STING1 Q86WV6 7/20 0.43
▸ PDE3B Q13370 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ PDE4A P27815 3/20 0.42
▸ PDE4B Q07343 3/20 0.42
▸ PDE4C Q08493 3/20 0.42
▸ PDE4D Q08499 3/20 0.42
▸ GMNN O75496 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RAPGEF4 Q8WZA2 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18742090 0.87 LMNA (0.43) LMNATHRBMTORMDM2NCOA1
SCHEMBL13176571 0.87 LMNA (0.50) LMNATHRBMTORMDM2NCOA1
SCHEMBL18744137 0.87 LMNA (0.50) LMNATHRBMTORMDM2NCOA1
SCHEMBL16561105 0.85 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL19954155 0.85 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL1331888 0.85 STING1 (0.57) LMNATHRBMTORMDM2NCOA1
SCHEMBL18720751 0.82 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL10239773 0.79 LMNA (0.42) LMNATHRBMTORMDM2NCOA1
SCHEMBL30847445 0.78 STING1 (0.54) LMNARAPGEF3STING1PDE3BPDE3A
SCHEMBL18720750 0.75 LMNA (0.41) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365605-B2 Cyclic nucleotide analogs ALIOS BIOPHARMA, INC. (US) 2016-06-14 — — US disclosed
Send feedback